Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Platensimycin

Base Information
  • Chemical Name:Platensimycin
  • CAS No.:835876-32-9
  • Deprecated CAS:898249-77-9
  • Molecular Formula:C24H27NO7
  • Molecular Weight:441.481
  • Hs Code.:
  • UNII:Q3DQ78KOFY
  • DSSTox Substance ID:DTXSID80894888
  • Nikkaji Number:J2.310.958A
  • Wikipedia:Platensimycin
  • Wikidata:Q423275
  • Metabolomics Workbench ID:102087
  • ChEMBL ID:CHEMBL411278
  • Mol file:835876-32-9.mol
Platensimycin

Synonyms:platensimycin

Suppliers and Price of Platensimycin
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Platensimycin
  • 250μg
  • $ 722.00
  • Usbiological
  • Platensimycin
  • 250ug
  • $ 582.00
  • TRC
  • Platensimycin
  • 500μg
  • $ 560.00
  • TRC
  • Platensimycin
  • 250μg
  • $ 350.00
  • Sigma-Aldrich
  • Platensimycin, Streptomyces sp. - CAS 835876-32-9 - CalbiochemA cell-permeable Streptomyces-derived antibiotic that exhibits broad-spectrum Gram-positive antibacterial activity by selectively targeting the elongation condensing enzyme FabF.
  • 250ug
  • $ 343.00
  • Sigma-Aldrich
  • Platensimycin, Streptomyces sp. - CAS 835876-32-9 - Calbiochem A cell-permeable Streptomyces-derived antibiotic that exhibits broad-spectrum Gram-positive antibacterial activity by selectively targeting the elongation condensing enzyme FabF.
  • 250 μg
  • $ 341.32
  • Cayman Chemical
  • Platensimycin ≥95%
  • 1mg
  • $ 1077.00
  • Cayman Chemical
  • Platensimycin ≥95%
  • 250μg
  • $ 300.00
Total 9 raw suppliers
Chemical Property of Platensimycin
Chemical Property:
  • PSA:136.65000 
  • LogP:3.88320 
  • Storage Temp.:?20°C 
  • Solubility.:DMSO: soluble1mg/mL, clear, colorless 
  • XLogP3:2.3
  • Hydrogen Bond Donor Count:4
  • Hydrogen Bond Acceptor Count:7
  • Rotatable Bond Count:5
  • Exact Mass:441.17875220
  • Heavy Atom Count:32
  • Complexity:888
Purity/Quality:

>95% by HPLC *data from raw suppliers

Platensimycin *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC12CC34CC1CC(C3C(C(=O)C=C4)(C)CCC(=O)NC5=C(C=CC(=C5O)C(=O)O)O)O2
  • Isomeric SMILES:C[C@]12C[C@]34C[C@H]1C[C@@H]([C@H]3[C@](C(=O)C=C4)(C)CCC(=O)NC5=C(C=CC(=C5O)C(=O)O)O)O2
  • General Description PlatensiMycin is a potent antibiotic effective against multi-resistant bacteria like MRSA and VRE, derived from a chiral synthetic intermediate through enantioselective synthesis involving catalytic asymmetric intramolecular cyclopropanation, enabling the development of its derivatives and analogs.
Technology Process of Platensimycin

There total 17 articles about Platensimycin which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With tris(dimethylamino)sulfonium trimethylsilyldifluoride; In N,N-dimethyl-formamide; at 40 ℃; for 1h;
DOI:10.1021/jo802261f
Guidance literature:
platensimycin methyl ester; With water; potassium hydroxide; In 1,4-dioxane; at 35 ℃; for 12h;
With hydrogenchloride; In 1,4-dioxane; water;
Guidance literature:
Multi-step reaction with 13 steps
1.1: potassium hydroxide; water / methanol / 0 - 20 °C
1.2: 0 °C
2.1: triethylamine / diethyl ether / -20 °C
3.1: diethyl ether / -20 - 0 °C
4.1: dirhodium tetraacetate / dichloromethane / 10 h
5.1: 1-ethyl-piperidine; hypophosphorous acid / water; methanol / 0.17 h / 0 °C
5.2: 0 - 20 °C
6.1: N-ethyl-N,N-diisopropylamine; lithium chloride / acetonitrile / 0.25 h / 0 °C
6.2: 0 - 20 °C
7.1: Dimethylphenylsilane / Wilkinson's catalyst / toluene / 20 - 60 °C
7.2: 1 h / -40 °C
7.3: 1 h / 0 °C
8.1: toluene-4-sulfonic acid / toluene / 2 h / Reflux; Dean-Stark trap
9.1: N,N,N,N,N,N-hexamethylphosphoric triamide; potassium hexamethylsilazane / toluene; tetrahydrofuran / 0.5 h / -78 °C
9.2: 1 h / -10 °C
10.1: potassium hydroxide; tert-butyl alcohol / 0.08 h / 60 °C
10.2: 14 h / 60 °C
11.1: potassium hydroxide; water / methanol / 2 h / Reflux
11.2: 20 °C
12.1: triethylamine; HATU / N,N-dimethyl-formamide / 15 h / 24 °C
13.1: potassium hydroxide; water / 1,4-dioxane / 12 h / 35 °C
With 1-ethyl-piperidine; N,N,N,N,N,N-hexamethylphosphoric triamide; Dimethylphenylsilane; water; hypophosphorous acid; potassium hexamethylsilazane; toluene-4-sulfonic acid; triethylamine; N-ethyl-N,N-diisopropylamine; HATU; lithium chloride; potassium hydroxide; tert-butyl alcohol; dirhodium tetraacetate; Wilkinson's catalyst; In tetrahydrofuran; 1,4-dioxane; methanol; diethyl ether; dichloromethane; water; N,N-dimethyl-formamide; toluene; acetonitrile;
upstream raw materials:

C29H39NO7Si

platensimycin methyl ester

C13H18INO2S

C10H10IN3O2

Downstream raw materials:

C25H31NO7

Refernces

Enantioselective divergent approaches to both (-)-platensimycin and (-)-platencin

10.1016/j.tet.2010.10.076

The research aimed to develop enantioselective divergent approaches for the synthesis of (-)-platensimycin and (-)-platencin, two new class antibiotics with potent activity against multi-resistant bacteria such as MRSA and VRE. The researchers designed a chiral synthetic intermediate with a useful a,b-unsaturated sulfone functionality, which served as a masked ketone and a good Michael acceptor. This intermediate was prepared via a highly enantioselective catalytic asymmetric intramolecular cyclopropanation (CAIMCP) developed in their laboratory. The CAIMCP of a-diazo-b-keto sulfone with CuOTf and bisoxazoline ligand 6 successfully afforded cyclopropane derivatives with high enantiomeric excess. The key intermediate 11 was used to synthesize both (-)-platensimycin and (-)-platencin through different synthetic pathways. The formal enantioselective total syntheses of both compounds were achieved, proving the applicability of the uniquely functionalized tricyclo[4.4.0.0]decene derivative and the usefulness of the CAIMCP in natural product synthesis. The study concluded that the developed chiral intermediate enabled the total syntheses of both antibiotics and could be useful for preparing their new derivatives and congeners.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 835876-32-9